Exome Asset Management’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-135,169
Closed -$3.45M 70
2024
Q1
$3.45M Buy
+135,169
New +$3.45M 2.95% 7